Powder extensively hydrolysed formula (0913101) vs Pdr disc/non ACBS protein SfI metabolic condition (0913442)
Powder extensively hydrolysed formula (0913101) was dispensed 40,676.0× as often as Pdr disc/non ACBS protein SfI metabolic condition (0913442) in April 2026 — 40,676 items versus 1 in England.
Powder extensively hydrolysed formula (0913101) · April 2026
NHSBSA Prescription Cost Analysis
Pdr disc/non ACBS protein SfI metabolic condition (0913442) · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913442): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Pdr disc/non ACBS protein SfI metabolic condition (0913442)
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Pdr disc/non ACBS protein SfI metabolic condition (0913442) |
|---|---|---|
| Items, April 2026 | 40,676 | 1 |
| Items, last 12 months | 489,597 | 17 |
| Net ingredient cost, April 2026 | £3,042,796 | £604 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Pdr disc/non ACBS protein SfI metabolic condition (0913442).